This briefing is based on Connecticut Public Act No. 24-59, Connecticut DEEP, EPA and FDA public materials. It is a business checklist, not legal advice, and it does not promise a platform, customs or regulatory outcome.
Why PFAS labeling matters now
PFAS are human-made chemicals used across consumer, commercial and industrial products. EPA describes PFAS as persistent chemicals that break down slowly and may be found in water, air, fish, soil and products. FDA's page updated on July 9, 2026 also notes that PFAS may enter food-related scenarios through environmental contamination, processing and cookware.
Connecticut's law focuses on certain products with intentionally added PFAS. For exporters and marketplace sellers, the practical task is to map product category, material treatment, supplier evidence, sales state and label wording before making any public claim.
Four fields to verify
| Field | Why it matters | Evidence to collect |
|---|---|---|
| Product category | State rules are category-specific. A Chinese product name is not enough. | English product name, intended use, platform category, package label |
| Intentionally added PFAS | The duty is tied to intentionally added PFAS, not vague supplier uncertainty. | BOM, formula statement, coating or water/oil resistance records |
| Sales state and timing | U.S. PFAS rules differ by state. Connecticut is a specific node, not a national rule. | Sales-state list, warehouse coverage, marketplace plan |
| Label and page wording | Packaging, listing copy and customer-service replies should match the evidence boundary. | Label draft, listing copy, test report, supplier declaration |
Keep the claim boundary conservative
PFAS work should not be described as guaranteed market access, guaranteed approval or a zero-risk conclusion. A safer statement is that the company is verifying product categories, intentionally added PFAS, supplier evidence and label wording for the target state.
绿色方舟（深圳）认证有限公司 can help teams organize product files, supplier declarations, label wording and evidence boundaries for review.
